HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic significance of right ventricular ejection fraction following inferior myocardial infarction.

Abstract
The prognostic significance of right ventricular ejection fraction, measured by radionuclide ventriculography, was assessed in 168 consecutive patients with inferior myocardial infarction. Right ventricular ejection fraction was 0.40 or less in 35 patients. Over a follow-up period of 40 months, there were 15 deaths in the total group of 168 patients, eight (23%) in the 35 with right ventricular ejection fraction of 0.40 or less, and seven (5%) in the remainder of the group. The one year survival of patients with right ventricular impairment (84 +/- 6%) was significantly worse (P less than 0.01) than those with a right ventricular ejection fraction over 0.40 (95 +/- 2%). A multivariate Cox model analysis showed age (P less than 0.001), left ventricular ejection fraction (P less than 0.01), and right ventricular ejection fraction (P less than 0.03) to be independent predictors of survival. Impaired right ventricular function is an adverse prognostic factor in patients with inferior infarction, particularly in those with impaired left ventricular function.
AuthorsT H Marwick, T M Birbara, K C Allman, J G Morris, D T Kelly, P J Harris
JournalInternational journal of cardiology (Int J Cardiol) Vol. 31 Issue 2 Pg. 205-11 (May 1991) ISSN: 0167-5273 [Print] Netherlands
PMID1869330 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Female
  • Humans
  • Life Tables
  • Male
  • Middle Aged
  • Myocardial Infarction (diagnostic imaging, mortality, physiopathology)
  • Prognosis
  • Radionuclide Ventriculography
  • Regression Analysis
  • Stroke Volume
  • Survival Rate
  • Ventricular Function, Left
  • Ventricular Function, Right

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: